US House Oversight Chair Questions PBM Leaders’ Testimony (2)

The chairman of a US congressional panel investigating prescription drug middlemen accused top industry executives of making false statements in testimony last month.

House Oversight and Accountability Committee Chairman James Comer, a Kentucky Republican, wrote to executives at CVS Health Corp., UnitedHealth Group Inc. and Cigna Group Wednesday asking them to correct remarks they made during a July hearing.

Pharmacy benefit managers have been under intensifying scrutiny in Washington, particularly since they’ve merged with larger entities that also control pharmacies, health plans and clinics. Industry representatives maintain that PBMs are a crucial counterweight to the pricing power ...